Skip to content

Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure

D. D’souza, S. Ganesh, J. Cortes-Briones, Michael H. Campbell, Maisha K. Emmanuel

Psychological Medicine October 16, 2019 DOI: 10.1017/s0033291719002721 via Semantic Scholar

Summary

AI-generated from the abstract

Heavy, chronic cannabis use that begins early and is not accompanied by other drugs is associated with more psychosis-relevant symptoms and poorer cognitive performance. Users averaged over 30,000 lifetime cannabis exposures and scored higher on the Schizotypal Personality Questionnaire (mean 24 vs. 13) and lower on a composite cognitive test (mean -0.23 vs. +0.28) compared to matched non-user controls. Moderate to large deficits appeared in attention, psychomotor speed, working memory, cognitive flexibility, visuo-spatial processing, and verbal memory. A subsample of users also showed worse outcomes than their non-using siblings.

Study at a glance

Characteristics Observational cohort Peer reviewed
Sample size 27
Population Members of a religious group whose lifestyle mandates heavy, chronic cannabis use and prohibits other substances, plus matched non-user controls from the same community
Keywords Medicine Psychology
Key finding Heavy, chronic, early cannabis use without other drug confounds is associated with elevated psychosis-relevant phenomena and cognitive deficits relative to matched non-user controls.

Abstract

Abstract Background The literature on psychosis-relevant outcomes in cannabis users does not adequately address the confounding effects of other substance use/misuse and psychiatric disorders. Methods We studied a unique population for whom cannabis use is central and necessary to their way of life. They are forbidden from using other substances, including tobacco and alcohol. Their use of cannabis is heavy, chronic, and begins early. The cases were compared with matched controls who did not use cannabis, alcohol, or drugs. The controls were from the same location and shared similar beliefs and lifestyle, except for cannabis use. Attenuated psychosis-relevant phenomena were assessed with the Schizotypal Personality Questionnaire (SPQ) and cognitive functioning with a culture-neutral computerized cognitive battery. Results Fifteen cases and 12 matched controls were studied. The cases averaged >30 000 lifetime cannabis exposures. Relative to controls, the cases had significantly higher mean (s.d.) SPQ scores 24 (14.32) v. 13 (8.92), p = 0.031; and poorer cognitive performance, reflected by a lower mean (s.d.) composite cognitive score −0.23 (0.32) v. +0.28 (0.52), p = 0.03. Moderate to large effect sizes were noted for differences in tests of attention, psychomotor speed, working memory, cognitive flexibility, visuo-spatial processing, and verbal memory. A subsample of cases had higher SPQ scores and worse cognitive performance than their siblings not using cannabis. Conclusion Heavy, chronic, and early cannabis use that is not confounded by other drug use is associated with psychosis-relevant phenomena and cognitive deficits. The findings are relevant to the evolving attitudes and laws about cannabis.

Comments

No comments yet.

Log in to comment